COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

Patent number:
Cataluña.svg
No items found.

A composition and methods for treating metabolic disorders, such as hepatic steatosis, adipose tissue dysfunction, and insulin resistance. Small interfering RNAs (siRNAs) targeting LPS-binding protein (LBP) that include unlocked nucleotides (UNA) and their therapeutic applications for the treatment of metabolic disorders are provided herein.

Countries:
Spain
Regions:
Catalonia
Centers:
UNIVERSITAT DE BARCELONA, FUNDACIO INST D INVESTIGACIO BIOMEDICA DE GIRONA DR JOSEP TRUETA IDIBGI
Other entities:
Centro de Investigación Biomédica en Red (CIBER) ; ARCTURUS THERAPEUTICS INC
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

-First therapeutic approach using lipid nanoparticles with modified siRNA against liver LPS-binding protein (LBP) for therapy for obesity-associated metabolic disturbances. -LUNAR® system: demonstrated successful, safe and potent siRNA delivery system. -Long term treatment (6 months) with repeated LUNAR®-Lbp UNA-siRNA weekly doses is well tolerated by the mouse liver -Not adverses cytokine profile of mice treated with LUNAR®-Lbp UNA-siRNA in long treated mice -LUNAR®-Lbp UNA-siRNA administration might stimulate tissue macrophage recruitment associated with an anti-inflammatory phenotype

Comments

Other related patents

Health

METHOD FOR THE SYNTHESIS OF CATIONIC CARBON NANOPARTICLES AND ITS APPLICATION FOR EFFICIENT GENE TRANSFECTION OF HUMAN CELLS

Countries
Spain
Know more
Health

Novel bioadhesive for wound closure in animals or humans

Countries
Spain
Know more
Health

Gelled microspheres for the vehicleization and release of therapeutic agents

Countries
Spain
Know more
Get back to patents directory